突発性難聴に対する高気圧酸素療法の効果―1次,2次治療別検討―

  • 三浦 誠
    京都大学大学院医学研究科耳鼻咽喉科・頭頸部外科 日本赤十字社和歌山医療センター耳鼻咽喉科
  • 坂本 達則
    京都大学大学院医学研究科耳鼻咽喉科・頭頸部外科
  • 平海 晴一
    京都大学大学院医学研究科耳鼻咽喉科・頭頸部外科
  • 金丸 眞一
    京都大学大学院医学研究科耳鼻咽喉科・頭頸部外科
  • 伊藤 壽一
    京都大学大学院医学研究科耳鼻咽喉科・頭頸部外科

書誌事項

タイトル別名
  • Evaluation of Hyperbaric Oxygen Therapy for the Treatment of Sudden Hearing Loss in Both Primary and Secondary Cases
  • リンショウ トッパツセイ ナンチョウ ニ タイスル コウキアツ サンソ リョウホウ ノ コウカ 1ジ 2ジ チリョウベツ ケントウ
  • 1次, 2次治療別検討

この論文をさがす

説明

This retrospective study included 256 cases with sudden hearing loss treated by hyperbaric oxygen therapy (HBO) in our hospital from 2000 to 2006 (57 primary cases with intravenous steroid administrations, and 199 secondary cases after insufficient effects of initial steroid therapy). Hearing thresholds were ascertained at frequencies of 250, 500, 1000, 2000, and 4000Hz using pure-tone audiometry. To establish the indication of secondary HBO therapy for the treatment of sudden hearing loss, several prognostic factors including initial average hearing thresholds, age, intervals between the onset and beginning of HBO treatment, and the presence or absence of vertigo at onset were evaluated between primary and secondary cases. Although the HBO effects in the secondary were poorer than those in primary cases, one third of the secondary cases indicated hearing threshold gains of over 10dB. Regardless of an age over 60 years, the presence of vertigo, and/or poor initial average hearing levels, HBO is considered to be an effective choice for secondary therapy of sudden hearing loss in patients within 8 weeks after onset.

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (12)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ